# PENICILLAMINE
> **ANDA213293** · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2021-08-19
## Drug
- **FDA Application Number:** ANDA213293
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PENICILLAMINE
- **Generic name:** PENICILLAMINE
- **Active ingredients:** PENICILLAMINE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** INVAGEN PHARMS
- **Manufacturer:** Cycle Pharmaceuticals Ltd.
- **First approval:** 2021-08-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213293)
---
*MORVS · CC0 1.0*